Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Elongation factor G (EF-G) – ribosome complex is a fundamental component of the bacterial protein synthesis machinery, responsible for the translocation step of translation (UniProt, 2024). Elongation factor G, a translational GTPase encoded by the fusA gene, binds to the ribosome and utilizes the energy from GTP hydrolysis to move the mRNA and tRNAs through the ribosomal subunits, a process essential for the continuous elongation of the polypeptide chain (PubMed, 2023). This complex serves as a primary target for several classes of antibiotics, most notably the steroid-like antibiotic fusidic acid, which prevents the release of EF-G from the ribosome after GTP hydrolysis (StatPearls, 2024). By stalling the ribosome in a post-translocational state, these drugs effectively inhibit bacterial growth and protein production. Mutations in the fusA gene are a common mechanism of clinical resistance, often reducing the affinity of the drug for the complex (NIH, 2022). Additionally, the complex plays a role in ribosome recycling, where EF-G works alongside ribosome recycling factor (RRF) to disassemble the post-termination complex. Given its essentiality in bacteria and structural differences from eukaryotic counterparts, it remains a key focus for antimicrobial drug discovery and structural biology research.
Inhibition of the translocation step of protein synthesis by stabilizing the EF-G-GDP complex on the ribosome or preventing EF-G binding to the ribosomal A-site.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elongation factor G (EF-G) – ribosome complex (EF-G – ribosome complex).